KRYSTAL-12: Adagrasib Significantly Improved PFS, Response in Certain Form of NSCLC
25 Jun 2024
Docwire News
Patients with previously treated KRAS-G12C-mutated NSCLC treated with adagrasib had significantly improved progression-free survival and overall survival.
Implications for Targeted Therapy: Genomic Profiling of USC Pancreatic Tumors
June 24, 2024